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IVA in addition to BMD can change the osteoporosis
management in 25 % of clinical routine patients
B. Aubry-Rozier, D. Stoll, M.-A. Krieg, O. Lamy, D. B. Hans
Bone Disease Unit, University Hospital, Lausanne, Switzerland
Introduction  Vertebral fracture is one of the major osteoporotic
fractures which are unfortunately very often undetected. In addition,
it is well known that prevalent vertebral fracture increases dramatically
the risk of future additional fracture. Instant Vertebral Assessment
(IVA) has been introduced in DXA device a couple of years ago to
ease the detection of such fracture when routine DXA are performed.
To correctly use such tool, ISCD provided clinical recommendation
on when and how to use it. The aim of our study was to evaluate the
ISCD guidelines in clinical routine patients and see how often it
may change of patient management.
Methods  During two months (March and April 2010), a medical
questionnaire was systematically given to our clinical routine patient
to check the validity of ISCD IVA recommendations in our popula-
tion. In addition, all women had BMD measurement at AP spine,
femur and 1/3 radius using a Discovery A System (Hologic, Waltham,
USA). When appropriate, IVA measurement had been performed
on the same DXA system and had been centrally evaluated by two
trained doctors for fracture status according to the semi-quantita-
tive method of Genant. The reading had been performed when pos-
sible between L5 and T4.
Results  Out of 210 women seen in the consultation, 109 (52 %)
of them (mean age 68.2 ± 11.5 years) fulfilled the necessary criteria
to have an IVA measurement. Out of these 109 women, 43 (inci-
dence 39.4 %) had osteoporosis at one of the three skeletal sites
and 31 (incidence 28.4 %) had at least one vertebral fracture. 14.7 %
of women had both osteoporosis and at least one vertebral fracture
classifying them as “severe osteoporosis” while 46.8 % did not have
osteoporosis and no vertebral fracture. 24.8 % of the women had
osteoporosis but no vertebral fracture while 13.8 % of women did
have osteoporosis but vertebral fracture (clinical osteoporosis).
Conclusions  In 52 % of our patients, IVA was needed according
to ISCD criteria. In half of them the IVA test influenced of patient
management either may changing the type of treatment of simply
by classifying patient as “clinical osteoporosis”. IVA appears to be
an important tool in clinical routine but unfortunately is not yet
very often use in most of the centers.
Previous fractures in healthy adolescent boys are asso-
ciated with reduced bone strength as assessed by
finite-element analysis at weight-bearing skeletal site
T. Chevalley, J.-P. Bonjour, S. Van Rietbergen, S. Ferrari, R. Rizzoli
Service of Bone Diseases, University Hospitals and Faculty of Medicine
of Geneva, Switzerland
In healthy children and adolescent boys, fractures result from trau-
ma of various severity. Whether these fractures are characterized
by an intrinsic bone biomechanical fragility remains to be demon-
strated. We reported in a cohort of 176 healthy adolescent boys pro-
spectively followed from age 7.5 ± 0.5 to 15.2 ± 0.5 yrs that frac-
ture history (156 fractures recorded in 87/176 boys) was associated
with decreased femoral neck (FN), areal (a) bone mineral density
BMD (–6.0 %, p = 0.005) measured by dual-energy x-ray absorpti-
ometry (DXA) and lower distal tibia trabecular volumetric (v) den-
sity (–5.5 %, p = 0.029) and number (–4.2 %, p = 0.040) as deter-
mined by high resolution peripheral computerized tomography
(HR-pQCT). In the present study, we assessed to which extent this
lower trabecular microstructure in the distal tibial among boys with
previous fractures was associated with reduced bone strength vari-
ables evaluated by micro-finite element analysis (µFEA) based on
HR-pQCT measurements. Associations between FN aBMD, distal
tibia microstructure and bone strength estimates, and fracture sta-
tus were evaluated by univariate logistic regression and expressed
as odds ratio (OR [95 % CI]) per 1 SD decrease. As compared to
those without fractures, boys with fractures had a 5.8 % lower bone
strength of the distal tibia as estimated by stiffness (245 vs. 260
kN/mm, p = 0.024) and failure load (11706 vs. 12430 N, p = 0.016),
after adjustment for age, standing height, body weight, pubertal
stage, calcium and protein intakes, physical activity, and calcium
supplement or calcium randomization between age 7.5 and 8.5 yrs.
At the distal tibia, the adjusted ORs (95% CI) for fracture per 1 SD
decrease were as follows: stiffness 1.53 (0.96–2.44, p = 0.072);
failure load 1.60 (0.99–2.60, p = 0.056); trabecular density 1.46
(1.02–2.09, p = 0.038); trabecular number 1.59 (1.04–2.42, p = 0.031).
The corresponding fracture OR for FN aBMD was: 1.80 (95 % CI
1.18–2.76, p = 0.006).
In conclusion, although trauma plays a non-negligeable role in the
occurrence of fractures in healthy children and adolescent boys, our
study provides evidence for an intrinsic component of skeletal fra-
gility as assessed by µFEA at weight-bearing site. The measured
biomechanical deficit at distal tibia corroborates indirect estimates
of fracture risk by assessing macro- and microstructural components
of bone mineral density and architecture.
A randomized controlled trial of music-based
multitask training to improve gait, balance and
reduce fall risk in the elderly
A. Trombetti 1, M. Hars 1, F. R. Herrmann 1, R. W. Kressig 2, S. L. Ferrari 1,
R. Rizzoli 1 
1Division of Bone Diseases, University Hospitals of Geneva, 2Depart-
ment of Acute Geriatrics, University Hospital of Basel, Switzerland
Background  Fracture prevention aims at reducing both bone loss
and fall risk. Falls occur mainly while walking or performing con-
current tasks. Measures to reduce falls are often complex and of
limited benefits. We aimed to determine whether a music-based
multitask training could improve gait, balance, and reduce fall risk
in elderly people.
Methods  We conducted a randomized controlled trial involving
134 community-dwelling individuals aged 65 years or older (76 ± 7
years), who were identified at increased risk of falling. They were
randomly assigned to an intervention group (n = 66) or a delayed
intervention control group scheduled to start the program 6 months
later (n = 68). The intervention was a structured program of weekly
1-hour group exercise classes featuring various multitask exercises
performed to the rhythm of improvised piano music (i.e., Jaques-
Dalcroze eurhythmics). Change in gait variability under dual-task
condition from baseline to 6 months was the primary end point.
Secondary end points included changes in gait, balance and func-
tional tests performances. Both groups were assessed at baseline
and months 6 and 12. Falls during follow-up were assessed using a
monthly calendar method with daily records.
Results  In an intent-to-treat analysis, at 6 months, there was a
reduction in stride length variability (adjusted mean difference,
–1.4 %; 95 %CI, –2.3 to –0.6; p = .002) under dual-task condition
in the intervention group, compared with the delayed intervention
control group. Usual gait speed, balance and functional tests im-
proved compared with the control group. There were fewer falls in
For personal use only. Not to be reproduced without permission of Krause & Pachernegg GmbH. 
22 J MINER STOFFWECHS 2011; 18 (SUPPLEMENTUM 2)
Table 2. Results, Zacchetti G et al.
Trabecular Weeks 4 8 12
Bone volume/ Controls 10.3 ± 3.0 4.8 ± 1.3 7.8 ± 2.0
total volume Strontium 17.7 ± 3.5 16.3 ± 2.4** 20.9 ± 2.8**
(%) ranelate
Thickness Controls 0.066 ± 0.005 0.062 ± 0.003 0.064 ± 0.005
(mm) Strontium 0.075 ± 0.005 0.081 ± 0.002** 0.082 ± 0.002**
ranelate
SMI Controls 2.78 ± 0.27 3.30 ± 0.24 2.88 ± 0.30
Strontium 2.25 ± 0.28 2.14 ± 0.13** 1.91 ± 0.23**
ranelate
** p < 0.01 vs time-control
Table 1. Results, Popp A W et al.
R² vBMD CtTh TbN TbSp Dinn Dmeta BV/TV
aBMD/T-DIA 0.846a 0.922a 0.090 0.073 0.029 0.001 0.001
aBMD/T-EPI 0.846a 0.462a 0.504a 0.410a 0.593a 0.672a 0.656a
ap < 0.01
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the intervention group (incidence rate ratio, 0.46; 95 %CI, 0.27 to 0.79;
p = .005) and a lower risk of falling (relative risk, 0.61; 95 %CI,
0.39 to 0.96; p = .02). Similar changes occurred in the delayed in-
tervention control group during the second 6-month period with inter-
vention. Benefit on gait variability measured in dual-task condition
persisted for 6 months after the program had ended.
Conclusions  These findings indicate that 6-month participation
in music-based multitask exercises classes once a week, can improve
gait performance under both single and dual-task conditions, as well
as balance, and reduce both the rate of falls and the risk of falling
in at-risk community-dwelling older adults.
Areal bone mineral density at distal tibia predicts
microstructure assessed by HR-pQCT
A. W. Popp, S. Brianza, K. Lippuner, A. E. Tami, R. G. Richards,
M. Windolf, D. Schiuma
AO Research Institute Davos, and Osteoporosis Policlinic, University
Hospital Bern, Switzerland
Background  The predictive value of areal bone mineral density
(aBMD) at the distal tibia regarding fracture risk has been demon-
strated in a population-based cohort of elderly women [Popp AW et
al. Osteoporos Int 2009]. While the adjusted hazard ratio of clinical
fractures was similar for the tibial diaphysis (T-DIA) and epiphysis
(T-EPI), the T-scores in both sub-regions were different: –1.6 SD at
T-DIA versus –2.4 SD at T-EPI. As mechanical properties of the
bone are also determined by its micro-architecture, the aim of the
current study was to evaluate the ability of DXA to predict micro-
structural parameters at the distal tibia.
Methods  Cadaveric tibiae from female donors were scanned with
DXA (Hologic QDR 4500 A™, Hologic, Bedford, MA, USA) and
high-resolution peripheral quantitative computed tomography (HR-
pQCT, XtremeCT™ Scanco Medical, Brüttisellen, Switzerland).
T-DIA and T-EPI were considered and parameters of interest were
aBMD, volumetric BMD, mean cortical thickness (CtTh), trabecu-
lar number (TbN) and trabecular spacing (TbSp) assessed by the
distance-transform method, inner trabecular density (Dinn) defined
as the inner 60 % and meta trabecular density (Dmeta) defined as
the outer 40 % of the trabecular region, and bone volume to total
volume ratio (BV/TV).
Results  Sixty tibias from 35 female donors were included in this
study, corresponding to 25 pairs and 10 single tibias. The mean (± SD)
age of the donors was 78.5 ± 9.3 yr with mean height of 160.1 ±
7.8 cm and mean weight of 57.2 ± 11.4 kg. T-scores for T-DIA and
T-EPI were –2.0 SD and –2.3 SD, respectively. No side-to-side dif-
ferences were found for the paired tibias (p > 0.05). aBMD corre-
lated highly with CtTh at T-DIA and substantially with trabecular
parameters at T-EPI according to the Table 1.
Conclusions  At the distal tibia, aBMD seems to reflect the micro-
architecture assessed by HR-pQCT with respect to cortical and trabec-
ular bone. Based on these results, T-DIA could apply as a region of
interest to investigate the relation between cortex and fracture risk.
A single high dose of oral vitamin D3 is insufficient
to correct a deficiency in a rheumatologic population
D. Stoll, O. Lamy, M.-A. Krieg, D. Hans, J. Dudler, A. So, B. Aubry-Rozier
Bone Disease Unit, University Hospital Lausanne, Switzerland
Introduction  Vitamin D plays a major role in bone metabolism
and neuromuscular function. Supplementation with vitamin D is
effective to reduce the risk of fall and of fracture. However adherence
to oral daily vitamin D is low. Screening and correcting vitamin D
insufficiency in a rheumatologic population could improve both
morbidity and quality of life. After determining the prevalence of
vitamin D deficiency in this population, we evaluated if supple-
mentation with a single high dose of oral 25-OH vitamin D3 was
sufficient to correct this abnormality.
Methods  During one month (November 2009), levels of 25-OH
vitamin D were systematically determined in our rheumatology out-
patient clinic and classified in: vitamin D deficiency (< 10 µg/l),
vitamin D insufficiency (10 to 30 µg/l) or normal vitamin D (> 30 µg/l).
Patients with insufficiency or deficiency received respectively a single
high dose of 300’000 IU or 600’000 IU oral vitamin D3. In addition,
all patients with osteoporosis were prescribed daily supplement of
calcium (1 g) and vitamin D (800 IU). 25-OH vitamin D levels were
reevaluated after 3 months.
Results  Vitamin D levels were initially determined in 292 patients
(mean age 53, 211 women, 87 % Caucasian). 77 % had inflammato-
ry rheumatologic disease (IRD), 20 % osteoporosis (OP) and 12 %
degenerative disease (DD). Vitamin D deficiency was present in 20
(6.8 %), while 225 (77.1 %) had insufficiency. Of the 245 patients
with levels < 30µg/l, a new determination of vitamin D level was
available in 173 (71 %) at 3 months.
Conclusion  Vitamin D insufficiency is highly prevalent in our
rheumatologic population (84 %), and is not adequately corrected
by a single high dose of oral vitamin D3 in > 50 % of the patients
with IRD and DD. In patients with OP, despite association of a
single high dose with daily oral vitamin D supplementation, 40 %
of patients are still deficient when reevaluated at 3 months.
Systemic treatment with strontium ranelate
markedly improves the healing of critical bone defect
G. Zacchetti, R. Rizzoli, P. Ammann
Division of Bone Disease, Dept of Rehabilitation and Geriatrics and
Faculty of Medicine, University Hospital of Geneva, Switzerland
Rapid bone defect filling with normal bone is a challenge in ortho-
pedics and dentistry. Systemic treatment with antiosteoporotic agent
able to stimulate bone formation may be potentially useful. Healing
of a critical bone defect is a model associating a phase of bone
resorption and of bone formation. Strontium ranelate which has been
shown to decrease bone resorption and to positively influence bone
formation, represents a potential agent able to stimulate bone de-
fect filling. To further explore this question, we set up a model of
critical bone defect performed at the level of the rat proximal tibia.
A drilling of 2.5 mm in diameter was created in the secondary spon-
giosa in 6 month-old female rats which were given strontium rane-
late (625 mg/kg/d, 5/7 days) or vehicle for 4, 8 or 12 weeks (10 rats
per group and per time point) starting at the moment of the surgery.
The tibias were removed for micro-tomographic histomorphometry
at the level of the healing bone defect at each time point. All results
are expressed as means ± SEM. One-way ANOVA with a Fisher
post-test was used to analyze the data (Table 2).
Strontium ranelate treatment induced an early increase of trabecu-
lar bone mass already visible by 4 weeks. This was associated with
improvement of the microarchitecture with a significant thickening
of the trabeculae visible after 4 weeks of treatment and increasing
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TNFα mediated osteoblastic inhibition of osteoclast
development is caused by a block in monocyte
differentiation
E. Atanga, S. Dolder, W. Hofstetter
Group for Bone Biology & Orthopaedic Research, Department of Clini-
cal Research, University of Bern, Switzerland
Background  Osteoclasts are bone resorbing multinucleated giant
cells. Previously, we demonstrated that TNFα inhibits the develop-
ment of osteoclasts in vitro through osteoblast-mediated mechanisms,
which were found to include Granulocyte-Macrophage-Colony-Stim-
ulating-Factor (GM-CSF). Within this study, the molecular mecha-
nism(s) of the inhibition of osteoclastogenesis mediated by TNFα
and the differentiation of haematopoietic progenitor cells were in-
vestigated.
Methods  Expression of haematopoietic cell surface markers
(RANK, c-kit, c-fms, CD11c, F4/80) during the development of
osteoclasts was investigated by FACS analysis in cultures of CSF-1
dependent non-adherent osteoclast precursor cells (OPC) grown with
CSF-1 (30 ng/ml) and RANKL (20 ng/ml). Levels of transcripts
encoding RANK, c-fms and NHA2 in cultures of OPC were assessed
by RT-PCR. Conditioned media (CM) were generated from primary
osteoblasts by collecting cell supernatants from cultures of cells
treated with TNFα/1,25(OH)2D3 after 72h.
Results  FACS analysis revealed that in cultures of OPC, grown
with 10 % CM from wt osteoblasts treated with TNFα/1,25(OH)2D3,
RANK and CD11c were no longer expressed. CM from GM-CSF–/–
osteoblasts did not block the expression of RANK, the cultures,
however, were negative for CD11c. Levels of F4/80 and c-fms in-
creased over time and no differences between CM from control and
treated cell cultures were observed. Levels of transcripts encoding
RANK were reduced by 50 % after 24 h and 75 % after 48 h when
the cells were grown with CM from wt osteoblasts, but only by 20 %
and 40 %, respectively, when cells were grown with CM from GM-
CSF–/– cells. Levels of transcripts encoding c-fms were not changed
in these cultures.
Conclusion  The reduction of RANK expression demonstrates that
the prevention of RANK-RANKL signalling is, at least in part, re-
sponsible for the inhibition of osteoclastogenesis by TNFα and that
the cells are maintained in an undifferentiated state rather than be-
ing diverted to become dendritic cells or granulocytes.
IL-17 alone in vitro supports osteoclastogenesis
but inhibits 1-25(OH)2 D3 mediated development of
osteoclasts
D. Balani, S. Dolder, R. Kamgang, D. Aeberli, W. Hofstetter, M. Seitz
Department of Rheumatology, Inselspital, Bern and Group for Bone Bio-
logy & Orthopaedic Research, Department of Clinical Research, Univer-
sity of Bern, Bern, Switzerland
Background IL-17 is a cytokine secreted by the Th17 subset of T-
cells. Suda et al. [J Clin Invest 1999; 103: 1345] reported increased
IL-17 levels in the synovial fluids of patients suffering from Rheu-
matoid Arthritis. In vitro IL-17 was shown to increase osteoclast
formation in a dose-dependent manner. The detailed role of IL-17 in
osteoclast development, however, remains to be elucidated. In the
present study the regulation of osteoclastogenesis by IL-17 was in-
vestigated.
Methods  Osteoclast development was studied in co-cultures of
murine osteoblasts (ddY mice) and bone marrow cells (BMC) from
C57Bl/6J mice and in cultures of CSF-1 dependent non-adherent
osteoclast progenitor cells (OPC). Cells were maintained in 48-well
plates with 10 nM 1-25(OH)2 D3 and IL-17 (0.1 ng/ml to 10 ng/ml)
alone and in combination both in low-density co-cultures (4 × 103
osteoblasts and 6 × 104 BMC) and high-density co-cultures (2 × 104
osteoblasts and 5 × 105 BMC). Levels of mRNAs encoding CSF-1,
RANKL, OPG, RANK, c-fms, calcitonin receptor (CTR) and sodi-
um-hydrogen exchanger NHA2 were determined in co-cultures.
Results  IL-17 alone induced osteoclast formation in the absence
of 1-25(OH)2 D3 only in high density co-cultures but did not affect
the formation of osteoclasts in cultures of OPC. However, in the
presence of 1-25(OH)2 D3 IL-17 caused a decrease in the number of
TRAP-positive cells in low and high density co-cultures. At 50 ng/ml
IL-17 abrogated 1-25(OH)2 D3 mediated osteoclastogenesis by 80 %.
Furthermore, gene-expression studies revealed a decrease in the
expression of RANK, CTR and NHA2 mRNA levels in high and low
density co-cultures in the presence of IL-17 and 1-25(OH)2 D3.
Conclusions  The present data shows that IL-17 supports osteo-
clastogenesis by replacing 1-25(OH)2 D3 in high-density co-cultures.
IL-17 does not exert its effects directly on hematopoietic precursors
of osteoclasts but mediates its effects via osteoblasts. IL-17 may be
capable of modulating the culture conditions favouring osteoclasto-
genesis in the absence of 1-25(OH)2 D3 and inhibiting the develop-
ment of osteoclasts in osteoclastogenic conditions.
PPAR beta-deficiency impairs muscle and skeletal
response to exercise
N. Bonnet, B. Desvergne 1, S. Ferrari
Division of Bone Diseases, Geneva University Hospital and Faculty of
Medicine, 1Center for Integrative Genomics, Faculty of Biology and
Medicine, University of Lausanne, Switzerland
Background  PPARβ is expressed in skeletal muscle and bone,
and promotes fatty acid oxidation in response to exercise. We found
that PPARβ-deficient mice have reduced muscle and bone mass and
altered bone microarchitecture, which worsen with age. We inves-
tigated the influence of PPARβ on muscle and skeletal responses to
exercise.
Methods  Bone mass and microarchitecture were monitored in fe-
male PPARβ–/– and PPARβ+/+ mice from 16 to 21 weeks of age.
Mice were subjected to moderate treadmill exercise (EXE) or un-
trained (UN). Relative expression of PPARβ and γ mRNA (normal-
ized for GAPDH) was evaluated in gastrocnemius and femurs by
qRT-PCR.
Results  In UN PPARβ+/+ mice, PPARβ mRNA was more abun-
dantly expressed than PPARγ in muscle (+65 % p < 0.001), but less
than PPARγ in bone (–49 %, p < 0.001). Exercise modestly in-
creased PPARβ expression (+16 %, ns and +38 % p < 0.05 vs UN,
respectively in muscle and bone) in PPARβ+/+ mice, whereas PPARγ
mRNA remained unchanged. In contrast, in PPARβ–/–, exercise sig-
nificantly increased PPARγ expression in muscle and bone (+90 %
and +40 %, respectively, vs UN, both p < 0.05). Compared to
PPARβ+/+, PPARβ–/– mice had lower maximal speed and capacity to
run a long distance. However, PPARβ–/– were able to perform the
moderate exercise in full. In PPARβ+/+ mice, EXE significantly in-
creased total body (TB) lean mass (21.7 ± 0.8 vs 19.3 ± 0.3 g in
UN, p < 0.05), femoral BMD (75 ± 1 vs 70 ± 0.4 mg/cm² in UN,
p < 0.01), and tibial BMD (54 ± 1 vs 50 ± 0.5 mg/cm² in UN,
p < 0.01). TB fat did not change significantly in response to exer-
cise. In these mice, EXE increased trabecular BV/TV and number
(TbN) at the distal femur (+121 % and +12.6 %, respectively vs UN,
all p < 0.05), and similarly at the tibia. It also increased cortical
bone volume (Ct.BV, 0.40 ± 0.01 vs 0.36 ± 0.01 mm3 in UN, p < 0.05)
and thickness (Ct.Th, 239 ± 9 vs 216 ± 3 µm in UN, p < 0.05) at the
tibia midshaft. In contrast, in PPARβ–/– mice, EXE had no effect on
TB lean mass, BMD, TbN, Ct.BV or Ct.Th either in the femur or
tibia. Hence we observed a significant interaction (Pinter < 0.05 by
2F_ANOVA) between genotype and EXE/UN on these parameters.
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progressively, illustrating the potential benefit of strontium rane-
late on bone formation. Finally as evaluated by SMI (3 = rod like,
1 = plate like) trabeculae are more plate-like (optimal structure for
mechanical resistance) in strontium ranelate treated rats than in
control. Strontium ranelate represents a potential intervention to
accelerate and enhance the filling of a bone defect, with potential
advantages in dental or orthopedic surgery for bone healing after
tooth extraction and for implant osseointegration.
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Conclusions  These results identify PPARβ as an important factor
for the muscle and skeletal response to exercise. In absence of PPARβ,
upregulation of PPARγ, particularly in bone, could further contrib-
ute to the lack of skeletal anabolic response to exercise. Whether
PPARβ regulates bone modeling/remodeling through its effects on
muscle and/or on bone cells is currently being investigated.
Pharmacological inhibition of interleukin-15 prevents
colitis and associated bone loss in IL-10 knockout
mice
B. Brounais-Le Royer 1 , S. Ferrari-Lacraz 2, D. Velin3, S. Ferrari 1,
D. Pierroz1
1Service of Bone Diseases and 2Transplantation Immunology Unit, Gen-
eva University Hospital, 3Service of Gastroenterology and Hepatology,
CHUV and University of Lausanne, Switzerland
Bone loss secondary to inflammatory bowel diseases (IBD) is largely
explained by activated T cells producing cytokines that trigger osteo-
clastogenesis and accelerate bone resorption while inhibiting bone
formation. In IBD, elevated expression of interleukin (IL) 15, a T cell
growth factor, plays a central role in T cell activation, pro-inflam-
matory cytokine production and the development of colitis. We pre-
viously reported that IL-15 enhances RANKL-induced osteoclasto-
genesis and that an IL-15 antagonist, CRB-15, prevents weight and
bone loss in a mouse model of dextran sulfate sodium-induced colitis.
We hypothesized that inhibition of IL-15 signaling might prevent
bone loss in IL-10 deficient mice, that develop spontaneous bowel
inflammation associated with osteopenia when they are no longer
raised under germ-free conditions. Mice received an IL-15 antagonist
(CRB-15,5 µg/day, n = 5) or IgG2a (5 µg/day, n = 4) from week 10
to 14 of age. The severity of colitis was assessed by histology and
bowel cytokines gene expression by real time PCR. Bone mass and
architecture were evaluated by ex vivo DXA on femur and micro-
computed tomography on femur and vertebra. Body weight gain
was similar in the two groups. After 4 weeks, colon was 29 % shorter
in CRB-15 treated mice (p < 0.006), a sign of reduced inflamma-
tion. Histological analysis indicated a transmural infiltration of in-
flammatory cells, lymphoepithelial lesions and increased size of
villi (histological score = 4/6) in IgG2a treated mice, whereas colon
from CRB-15 treated mice exhibited mild infiltration of inflamma-
tory cells of the lamina propria, no mucosal damages and a minimal
increased size of villi (histological score = 1.6/6). Levels of TNFα,
IL-17 and IL-6 mRNA in the colon were significantly reduced in
CRB-15 treated mice (p < 0.04 vs IgG2), indicating a decrease in
colon inflammation. CRB-15 improved femur BMD (+10.6% vs
IgG2a, p < 0.002), vertebral trabecular bone volume fraction (BV/
TV, +19.7% vs IgG2a, p < 0.05) and thickness (+11.6 % vs IgG2a,
p < 0.02). A modest but not significant increase in trabecular BV/
TV was observed at the distal femur. Cortical thickness was also
higher at the midshaft femur in CRB-15 treated mice (+8.3 % vs
IgG2a, p < 0.02). In conclusion, we confirm and extend our results
about the effects of CRB-15 in colitis. Antagonizing IL-15 may exert
favorable effects on intestinal inflammation and prevent bone loss
and microarchitecture alterations induced by colitis.
Characterization of osteoprogenitors functionally
isolated from human mesenchymal stem cells by a
Runx2 reporter adenovirus
M. Bruderer 1, 2  , M. J. Stoddart 1, M. Alini 1
1AO Research Institute, Davos, 2Laboratory for Biologically Oriented
Materials, Department of Materials, ETH Zurich, Switzerland
Background  Mesenchymal stem cells (MSC) are a heterogeneous
cell population characterized by their self-renewal capability and
their multidifferentiation potential. Current isolation methods of MSCs
are still rudimentary due to the lack of a unique marker. Here, we
report a novel method for the identification and isolation of osteo-
progenitors from human MSCs, along with the characterization of
the resulting cell populations. A subpopulation of MSCs was func-
tionally identified and isolated by coupling the expression of the
key osteogenic transcription factor Runx2 to the expression of en-
hanced green fluorescent protein (EGFP) via a Runx2 reporter ade-
novirus. On that basis, fluorescing cells can be selected by means
of fluorescence activated cell sorting (FACS).
Materials and methods  MSCs were obtained from bone marrow
aspirates by Ficoll separation and cell attachment to plastic. MSCs
were expanded in the presence of bFGF. Cells were infected with
the Runx2 reporter adenovirus. High efficiency transduction of MSCs
was achieved using lanthofection at 100 MOI. Cells were then sub-
jected to osteogenic induction for 3 days and sorted by means of
FACS. The resulting cell populations, namely Runx2 GFP+, Runx2
GFP–, and the unsorted cells, were separately expanded in the pres-
ence of bFGF, and thereafter subjected to comparative in vitro inves-
tigation for their ability to differentiate into the osteogenic lineage.
To substantiate the characterization of the cell populations, prolif-
erative capacity of the cell populations was also assessed. Osteo-
genic differentiation was evaluated by alkaline phosphatase (ALP)
activity at d7, 14, and 21, as well as 45Ca incorporation at d21.
Results  Colony forming unit (CFU) analysis at d14 revealed that
Runx2 GFP+ cells proliferate at a slower rate than the other two
groups. This suggests that Runx2 GFP+ cells show a more commit-
ted/differentiated phenotype than the other two cell populations.
ALP activity of Runx2 GFP+ cells was shifted towards earlier time-
points, showing highest ALP activity at d7 as opposed to d14 for the
other two groups. 45Ca incorporation was massively higher for osteo-
genically differentiated Runx2 GFP+ cells than for the other cell
populations treated with the same medium. Results of both assays
are in accordance with each other, indicating that Runx2 GFP+ cells
are more osteogenic than Runx2 GFP– and unsorted cells.
Conclusion  We have made use of a Runx2 reporter adenovirus to
sub-divide human MSCs. Reporter-positive subpopulation displays
characteristics appropriate for osteoprogenitors: (1) a slower prolif-
eration rate, and (2) a more osteoblast-like phenotype upon in vitro
osteogenic differentiation, as compared with reporter-negative as
well as original cell population.
In-vitro prevascularisation of a 3D scaffold using
autologous endothelial progenitor- and mesenchymal
stem cells
F. Duttenhoefer 1, 2  , R. Lara de Freitas1,3, M. Loibl 1, G. Richards1, M. Alini 1,
S. Verrier 1
1AO Research Institute Davos, Switzerland, 2Department of Oral and
Maxillofacial Surgery, Albert-Ludwigs-University, Freiburg, Germany,
3Medical School of Ribeirão Preto, University of São Paulo, São Paulo,
Brazil
Background  Angiogenesis is a key factor in early stages of wound
healing and is also crucial for tissue regeneration. In cases of large
bone defects, to date most of the efforts have been focused on the
filling of the gap with autologous bone grafts, or various bio-active
materials associated or not with bone forming cells. However, the
neo-vascularisation of such implants is still a limiting factor. The
aim of the present study is to develop a pre-vascularised hybrid
bone implant made of a polyurethane scaffold seeded with auto-
logous cells; Endothelial Progenitor Cells (EPC) and Bone Marrow
Mesenchymal Stem Cells (BMSC).
Methods  BMSCs were isolated by Ficoll-Paque density-gradient
centrifugation from human bone marrow (KEK_Bern126/03). EPCs
(CD133+/CD34+) were isolated from BMSC fractions using mag-
netic-activated cell sorting (MACS®). After cell fluorescent stain-
ing using PKH67-green for EPC and PKH26-red for BMSC, EPCs
were seeded on 2D growth-factor-reduced-Matrigel coating alone
or together with BMSC. Cellular network formation was observed
using epifluorescence microscopy. In 3D co-culture set-ups, cells were
seeded in different proportions in a polyurethane scaffold in presence
of Platelet Rich Plasma. After 7 days of culture in different media
(osteogenic, angiogenic, or mixed), cryosections were performed and
stained with toluidine blue and endothelial-cell specific antibodies.
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Results  On Matrigel assay, EPCs showed the capacity to re-or-
ganize themselves in typical endothelial-like cellular networks and
demonstrated improved tubular-like formation when co-cultured with
BMSCs. In 3D scaffolds, we showed that the association EPC-BMSC
within a polyurethane scaffold promoted the formation of Laminin,
von-Willebrand-factor and PECAM positive tubular structures for-
mation.
Conclusion  EPC-BMSC co-culture in 2D- and 3D-environment
enhanced the formation of early tubular structures within the scaffolds
with both cell types contributing to this cellular re-organization. In
vitro pre-culture for 7 days with 50–50 cell proportion in osteogenic
media containing PRGF seems to be optimal.
Silica improves cell viability and modulates growth
factor release in platelet rich plasma-alginate-
hydrogels
M. Gimeno-Fabra1, 2, M. Peroglio1 , D. Eglin1, M. Alini 1, C. C. Perry 2
1AO Research Institute Davos, Switzerland, 2Biomolecular and Materi-
als Interface Research Laboratory, School of Science and Technology,
Nottingham Trent University, Nottingham, UK
Background  Platelet-rich plasma (PRP) is an autologous source
of growth factors derived from blood plasma that holds great promise
in various clinical applications (maxillofacial surgery, spinal fusion,
bone augmentation, treatment of soft tissues). In typical prepara-
tions, the release kinetics of pure PRP is very fast (more than 95 %
released in the first hour). In recent years, it has been shown that
combined growth factor delivery is more effective than delivery of
a single factor as growth factors play a different role in a time de-
pendent manner. The aim of this study was to validate for the first
time the use of a novel PRP-alginate-silica composite gel for com-
bined controllable PRP release and cell-based therapy.
Materials and methods  Sodium metasilicate nonahydrate (Na2SiO3,
9H2O) (5, 25 and 50 mM) was added to a 0.5 % sodium alginate
solution in Iscoves Modified Dulbecco’s medium and then mixed
with an equal volume of a PRP/thrombin solution. Macro-beads were
formed by adding the mixture dropwise into a CaCl2 solution (pH 7)
containing pentaethylenehexamine (PEHA). Gel beads were charac-
terized by FT-IR and scanning electron microscopy (SEM). Total pro-
tein and TGF-β1 release kinetics were also quantified. Once the
pH and ionic strength had been adjusted (pH = 7.4 and 330 mOsm)
for the different solutions, mesenchymal stem cell encapsulation
(hMSCs) could be encapsulated and cultured for 3 days. After dis-
solution of the beads, the proportion of viable cells was measured
by the trypan blue exclusion assay.
Results  Silica polycondensation occurred in PRP-alginate-silica as
shown by additional vibrational bands in FT-IR spectra (1000 cm–1,
950 cm–1 and 450 cm–1) and aggregated silica particles in fractured
and calcined PRP-alginate-silica beads examined by SEM. For the
PRP-alginate-silica beads, the amount of protein initially released
was approximately 80 % after 2 hr and slow protein release continued
over the next 78 hr. All the sodium metasilicate containing beads
showed a slower and significantly higher release of TGF-β1 at 48 h
than the PRP-alginate. After one day of culture, the addition of silicate
significantly increased the proportion of viable cells, both in alginate
and PRP-alginate samples as compared to alginate and PRP-algi-
nate without silicate, suggesting that the presence of the silicate in
the preparation reduces any negative effect of the alginate gel forma-
tion on cell viability. After three days of culture, the proportion of
viable hMSC in the PRP-alginate-silica samples was high (92 %),
independent of the silicate concentration.
Conclusions  In summary, we have reported a novel method for
combined controlled PRP release and mesenchymal stem cell en-
capsulation. The synthetic approach described in this contribution
combining silica with alginate could offer for the first time the op-
portunity to tune PRP growth factor release. Furthermore, this com-
posite system is injectable and preserves the viability of hMSCs
and therefore holds promise for combined tissue engineering and
drug delivery applications.
Modulation of Matrix Metalloproteinase-1 (MMP-1)
expression in human osteosarcoma cells directly
affects intratibial tumor formation and lung
metastases in mice
K. Husmann, M. J. E. Arlt, R. Muff, B. Langsam, J. Bertz, W. Born,
B. Fuchs
Laboratory for Orthopedic Research, Department of Orthopedics, Balgrist
University Hospital, University of Zurich, Zurich, Switzerland
Background  Osteosarcoma (OS) is the most frequent primary ma-
lignant tumor of bone, predominantly affecting children and young
adults. Patients with metastatic disease at diagnosis have a poor
prognosis. Metastatic progression is a complex process in which
tumor cells colonize distant target organs. Several steps during this
process require extracellular proteolytic enzymes. Overexpression
of MMP-1, a member of the matrix metalloproteinase family, has
been associated with poor prognosis in a variety of human cancers.
Methods  LacZ-tagged HOS (HOS/LacZ) cells stably overexpressing
MMP-1, 143B (143B/LacZ) cells downregulated in MMP-1 expres-
sion by siRNA and control cell lines were generated by retroviral
infection. These cell lines were used in different in vitro assays and
in vivo tumor models to investigate the functional relevance of MMP-1
in OS metastasis.
Results  MMP-1 was found upregulated in the highly metastatic
143B OS cells in comparison to its parental, non-metastatic HOS
cells. The biological relevance of this finding was further investi-
gated in vitro and in vivo. Overexpression of MMP-1 in HOS/LacZ
cells enhanced adhesion to collagen type I compared to control cells
and facilitated anchorage-independent growth. Conversely, siRNA-
mediated downregulation of MMP-1 expression in 143B/LacZ cells
inhibited the adhesion to collagen type I and reduced the number of
fast-growing cell colonies in soft agar. These findings in vitro suggested
that robust expression of MMP-1 in 143B/LacZ cells and in stably
MMP-1 infected HOS/LacZ cells may have a significant impact on
the metastatic activity of these cell lines in vivo. This was confirmed
in SCID mice upon intratibial injection of MMP-1 expression mod-
ified HOS/LacZ and 143B/LacZ cells, respectively, and of the cor-
responding control cells. MMP-1 overexpressing HOS/LacZ cells,
unlike the control cells, formed intratibial, osteolytic primary tumors
and numerous micrometastases in the lung. Conversely, 143B/LacZ
cells with siRNA-downregulated MMP-1 expression formed smaller
intratibial primary tumors and a significantly lower number of lung
macrometastases than the control 143B/LacZ cells.
Conclusions  In conclusion, MMP-1 is a key modulator of intra-
tibial primary tumor growth and of lung metastases of human 143B
and its parental HOS OS cells in mice.
Osteogenic potential of total BMC (bone marrow
mononucleated cells) versus EPC-depleted-BMC
fraction (endothelial progenitor cells)
R. Lara de Freitas1,2, F. Duttenhoefer1,3, M. Loibl 1, G. Richards1, M. Alini 1,
S. Verrier1
1AO Research Institute Davos, Switzerland, 2Medical School of Ribeirão
Preto, University of São Paulo, São Paulo, Brazil, 3Department of Oral
and Maxillofacial Surgery, Albert-Ludwigs-University, Freiburg, Ger-
many
Introduction  Endothelial cells-osteoblast co-cultures are known
to induce a synergy of cell differentiation and activity [1, 2]. Bone
marrow is a rich source of mesenchymal stem cells (MSC), but EPC
are also present. MSC can develop an osteogenic phenotype while
EPC will differentiate into endothelial cells. The aim of our study
was investigate the effect of the EPC present within the whole BMC
population on the MSC osteogenic differentiation.
Methods  Human BMC of 5 donors (KEK Bern 126/03) were iso-
lated by density gradient centrifugation (Ficoll). CD133+ and CD34+
cells were further depleted from the BMC using magnetic beads
(Miltenyi), the resulting population was named MM. Identical num-
bers of BMC and MM cells were seeded and culture over 28 days
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in classical osteogenic medium (10 nM Dexamethasone), or in auto-
logous growth factor medium (PRGF). PRGF was prepared from
thrombocyte concentrates resuspended in PBS (2 × 106 platelets/mL).
Cell growth was assessed by DNA quantification, osteogenic dif-
ferentiation by real-time (RT) PCR, and ALP activity. Matrix min-
eralization was estimated by 45Ca2+ incorporation.
Results  In both culture media, the full BMC grew faster than MM.
However, if PRGF showed an overall superiority for both popula-
tions’ cell growth, cell differentiation was much higher in Dex+
medium, for both BMC and MM. MM showed high up-regulation
of all tested osteogenic marker genes in both media. Cell differen-
tiation was confirmed by ALP activity that was found higher in MM
compared to BMC in both media, with higher values for Dex medi-
um. Matrix mineralization analyses confirmed these results.
Discussion  The EPC present in full BMC may grow faster than
the MSC (especially in PRGF3) and impair the proportion of cell
with osteogenic potential. These 2-cell populations also might be
in too early stages of differentiation to promote co-differentiation at
this point.
References:
1. Villars et al., 2002.
2. Hofmann et al., 2008.
3. Lippross et al., 2011.
PPARγ-null mice have increased cancellous bone
volume but low bone mass
D. D. Pierroz 1 , H. Fu 2, B. Desvergne2, S. L. Ferrari 1
1Service of Bone Diseases, Geneva University Hospital and Faculty of
Medicine, Geneva, 2Center for Integrative Genomics, Faculty of Biology
and Medicine, University of Lausanne, Switzerland
The nuclear receptor PPAR gamma (PPARγ) positively regulates
adipogenesis and negatively osteoblastogenesis. PPARγ+/– mice were
characterized by high bone mass and increased cancellous bone
volume (BV/TV). However, the skeletal effects of homozygous
PPARγ–/– deletion are unknown due to the lethality of PPARγ–/– mice.
Using novel recombinant technology, we were able to generate liv-
ing adult PPARγ–/– mice. Bone mass, architecture and turnover were
assessed in young and mature adult (3 and 6 months) and old (12
months) PPARγ+/+, PPARγ+/– and PPARγ –/– mice. Six and 12 month-
old PPARγ–/– mice had significantly increased lean mass (28.8 ± 0.6
vs 20.8 ± 1.8 g, p < 0.009), but lower % fat and low leptin levels
(0.23 ± 0.01 vs 8.22 ± 2.54 ng/mL, p < 0.05) compared to PPARγ+/+
and PPARγ+/–. Whereas in young PPARγ–/– mice, femoral length and
bone mass were decreased, there were trends for increased BV/TV and
decreased cortical bone area compared to PPARγ+/+ and PPARγ+/–.
With age (6 months), PPARγ –/– developed a greater (BV/TV) and
trabecular number compared to PPARγ+/+ and PPARγ+/–, but lower
bone density and cortical area and width compared to PPARγ+/–.
Similar results were found in old PPARγ–/– with more prominent
cortical and cancellous differences (Table 1).
Osteocalcin was decreased and markers of bone resorption were
increased in 6 and 12 month-old PPARγ –/– compared to PPARγ+/–
and PPARγ+/+. These results indicate that PPARg played an impor-
tant role on bone acquisition and maintenance with age and that
PPARγ deletion leading to lipodystrophy was associated with high
BV/TV but low bone mass, possibly due to loss of positive peripheral
leptin effects on cortical bone.
Short period of delayed loading can increase the
final bone volume inside tissue engineering
scaffold
A. Roshan-Ghias, D. P. Pioletti
Laboratory of Biomechnical Orthopedics, Ecole Polytechnique Fédérale
de Lausanne, Switzerland
Background  In our previous study, we showed that early cyclic
loading following the implantation of bone scaffold increases the
rate of bone formation in polymeric scaffolds in a period of 13 weeks
compared to the control group. We also found out that there is an
initial decrease in bone volume in the loaded group. The goal of
this study was to investigate the effect of a delayed loading follow-
ing the implantation of bone scaffold in a longer time period.
Methods  Both femoral condyles of 8 female Wistar rats of weight
245–250 gr. were drilled (Veterinary Authority from the Canton of
Vaud, authorizations No. 2140) and PLA + 5 % wt β-TCP scaffolds
of the same size were implanted inside the drilled holes. No cells
or growth factors were added in the scaffold. In the previous study,
the loading started 3 days after the surgery. In the present study, the
loading started two weeks after the surgery. The right knee joints of
all animals were loaded and the left leg was kept as control. Com-
pressive load of 10 N at 4 Hz for 5 minutes was applied by a cus-
tom-made compression machine. The animals were loaded 5 times
every other day. Both knee joints of all animals were scanned at 8
time points using SkyScan 1076 in vivo scanner (SkyScan, Belgium)
at 2, 4, 6, 7, 11, 15, 22 and 35 weeks after surgery. Bone volume
(BV) and BMD of bone inside scaffold were measured. Non-linear
mixed-effect modeling was used to model the evolution of BV and
BMD as a function of time. Repeated measures analysis of covari-
ances (ANCOVA) was used to evaluate the differences between the
two groups.
Results  Statistical test reveals that loading increases the rate of
bone formation by 8 % and the final bone volume by 18 %. No
difference in BMD between the control and loaded groups was ob-
served. Histological observations revealed that two distinct patterns
of bone formation were observed inside the scaffold. Close to the
exterior part, i.e. in the cortical region of bone, pores are completely
filled with bone, as if cortical bone is forming. In the trabecular
region, the bone is formed mainly on the walls of the scaffold pores,
as if trabecular bone is forming.
Conclusions  We had previously shown that early cyclic loading
increases rate of bone formation inside scaffold on the long run, but
at the cost of an initial decrease in the bone formation compared to
the control group. In this study, we delayed the loading period by
two weeks, and we saw that the initial decrease in bone formation
disappeared. However, the rate of bone formation was decreased by
half on the long run compared to the previous study using early
loading. Nevertheless, the effect of this short period of loading was
long lasting and it increased the final bone volume by 18 % com-
pared to the control group.
The surgical preparation of the bone-scaffold
interface is critical for bone regeneration
A. Roshan-Ghias, D. P. Pioletti
Laboratory of Biomechnical Orthopedics, Ecole Polytechnique Fédérale
de Lausanne, Switzerland
Background  The goal of this study was to investigate if the prepa-
ration of implantation site has an impact on bone formation inside
tissue engineering scaffold. Two drilling techniques were used to cre-
ate a hole in rat distal femur before the insertion of a bone scaffold.
The first drilling technique used a manually driven wood drill bit
and the second technique used an electrically driven metal drill bit.
Methods Sixteen female Wistar rats (weight 245–250 gr) were
randomly separated in two groups of eight, A and B, based on the
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Table 1. Pierroz D D et al.
6 months PPARγ+/+ PPARγ+/– PPARγ–/–
(n = 3) (n = 9) (n = 6)
Fem BMD (mg/cm2) 79.0 ± 6.8 87.5 ± 2.1 77.9 ± 3.9b
Dist fem Tb N (/mm) 3.20 ± 0.11 3.23 ± 0.20 3.91 ± 0.26a, b
Vert BV/TV (%) 13.3 ± 1.9 11.6 ± 1.8 20.2 ± 2.7 a, b
Vert TbN (/mm) 3.48 ± 0.11 3.62 ± 0.15 4.65 ± 0.21a, b
Midfemur Bone Area (mm2) 0.83 ± 0.03 0.97 ± 0.02a 0.81 ± 0.04b
Midfemur cort width (µm) 202.6 ± 4.4 221.2 ± 3.8 a 202.2 ± 4.9b
ap < 0.05 vs PPARγ+/+; bp < 0.05 vs PPARγ+/–
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drilling method: A) Wood drill bit used, B) metal drill bit. Note that
the cutting geometry is essentially different between groups A and B.
Left distal femurs were operated (Veterinary Authority from the
Canton of Vaud, authorization No. 2140) following a protocol already
used in our laboratory. The scaffold was a biocomposite made of
PLA/β-TCP. In vivo prospective micro-CT scanning was done in
order to investigate bone regeneration inside scaffolds (Skyscan
1076, Skyscan, Belgium) at six time points between 2 and 21 weeks
after the surgery. The BMD of each sample was quantified based on
the calibrated values of the phantoms. Linear mixed-effect mode-
ling was used to model the evolution of BV as a function of time
according to our previous study. Repeated measures analysis of co-
variances (ANCOVA) was used to evaluate the differences between
the two groups.
Results The amount of bleeding due to drilling was remarkably
higher in group A compared to group B (based on visual observa-
tions). The ANCOVA test shows that the group A has significantly
higher BV (p-value = 0.0005) and BMD (p-value = 0.0004) com-
pared to group B. We observed that group A is almost three weeks
ahead of group B in terms of bone regeneration. The structure of the
bone at the two surfaces is clearly different; the metal drill (group B)
has crushed and sheared the bone and the interface is partly clogged.
On the other hand, the wood drill (group A) has resulted in a clear
cut and the pores at the surface are more open.
Conclusions  The major finding of this study was to demonstrate
that the drilling technique strongly affects bone formation in scaf-
fold. Indeed we found that depending on the technique used, bone
healing process can be accelerated by almost three weeks in this in
vivo rat study. Thermal damage in group B is unlikely because the
duration of drilling and thickness of cortical bone are well below
critical values. The probable explanation is the difference between
amounts of blood extravasation which is due to the different cutting
geometry. In conclusion, by using a “wood” type drill, a faster bone
healing is obtained compared to a “metal” type drill, the latter being
usually used in clinical practice.
Caprin-1 expression promotes intratibial xenograft
growth and lung metastasis in mice and indicates
poor prognosis of patients with osteosarcoma
A. Sabile1 , M. Arlt 1, R. Muff 1, D. Hess 2, B. Langsam1, J. Bertz1,
T. Jentzsch1, W. Born1, B. Fuchs1
1University Hospital Balgrist, Department of Orthopedics, Zurich,
2Friedrich-Miescher-Institute, Basel
Background  Osteosarcoma is the most frequent primary malignant
bone tumor in children and adolescents with a high propensity for
lung metastasis, the major cause of disease-related death. Reliable
outcome-predictive markers and targets for osteosarcoma metastasis-
suppressing drugs are urgently needed. Recently, we demonstrated
that overexpression of the extracellular matrix protein Cyr61 pro-
motes primary tumour growth and lung metastasis in an intratibial
xenograft model in mice and indicates poor prognosis of patients
with osteosarcoma [Sabile A et al., submitted]. In the present study,
we investigated the putative Cyr61-interacting protein, Caprin-1
(cytoplasmic activation/proliferation-associated protein-1), as a
novel osteosarcoma-promoting protein.
Methods  We have immunoprecipitated endogenous Cyr61 with a
specific antibody and performed mass spectrometric analysis to iden-
tify Cyr61-interacting proteins. The effect of stable overexpression
of human Caprin-1 on primary tumor growth and metastasis was
assessed in vitro and in vivo in an orthotopic mouse osteosarcoma
model.
Results  We identified Caprin-1 as a novel Cyr61-interacting protein.
Furthermore, we showed that Caprin-1 overexpression in osteosar-
coma cell lines enhanced their migration and invasion rates in vitro,
reflecting enhanced metastatic potential. Finally, we demonstrated
that Caprin-1 overexpression accelerated primary tumor growth in
the tibia, increased the number of lung metastatic lesions, and con-
sequently significantly decreased mouse survival.
Conclusions  Using a proteomics approach, we identified Caprin-1
as a novel Cyr61-interacting protein. Furthermore, we demonstrate
that Caprin-1 overexpression promotes primary tumor growth and
enhances lung metastasis in vivo. Currently, we are investigating in
detail the interplay between Cyr61 and Caprin-1 and their functions
in the context of osteosarcoma metastasis.
Non-invasive monitoring of implant strength in-vivo
V. A. Stadelmann1, 2  , C. Conway 1, S. K. Boyd 1
1McCaig Institute for Bone and Joint Health, University of Calgary,
Canada, 2AO Research Institute, Davos, Switzerland
Background  Immediately after implantation, a dynamic process
of bone formation and resorption takes place around an orthopedic
implant, influencing its mechanical fixation. The delay until com-
plete fixation depends on local bone architecture and metabolism.
Despite its importance, for post-operative care, the temporal pat-
tern of implants fixation is still unknown. The aim of this study was
to evaluate the potential of micro finite-element modeling based on
in vivo micro computed tomography to monitor longitudinally the
evolutions of bone around an implant and of the implant strength in
vivo.
Methods  Titanium cancellous bone screws (ø = 1.7 mm, L = 5 mm)
were inserted surgically in the proximal tibias of twelve female
Wistar rats (3 months old, 240 ± 8 g). Bone growth around the
implant was assessed using in-vivo micro-computed tomography at
days 0, 3, 6, 9, 14, 20 and 27 at a resolution of 12 µm in 10 animals
(x-ray group). Two control rats were scanned only at days 0 and 27
and served as radiation controls (control group). The bone in con-
tact with the implant was evaluated from the scans and micro fi-
nite-element models were built from the image data to simulate the
screws’ pullout strength at each time point. The finite-element re-
sults were calibrated with biomechanical pullout after euthanasia.
Results  Contact bone volume fraction increased from 43 ± 7 % to
55 ± 8 % between day 0 and day 27 (p < 0.05). The pullout stiffness
increased from 137 ± 30 N/mm to 265 ± 45 N/mm (p < 0.05) and
failure load from 105 ± 30 N to 180 ± 20 (p < 0.05). These increas-
es were most prominent between day 0 and day 14. No significant
differences in stiffness or failure load were measured between the
monitoring group and the radiation control group.
Conclusions  Limitations, such as image artifacts and radiation,
still compromise the immediate clinical application of this method,
but it has a promising potential in preclinical studies, as it provides
very valuable data about the dynamic aspect of implant integration
with considerably reduced animal resources.
P38α MAPK regulates osteoblast function and
bone formation
C. Thouverey, J. Caverzasio
Service of Bone Diseases, Geneva University Hospital, Switzerland
Various osteogenic ligands that stimulate osteoblast differentiation
and function act, in part, through the p38 mitogen-activated protein
kinase (MAPK) pathway. A recent in vivo investigation has high-
lighted the physiological role of the TAK1-MKK3/6-p38 pathway
in osteoblastogenesis and bone formation. Interestingly, the authors
have shown that p38β is critical for late osteoblast differentiation
and that loss of p38β is not compensated by p38α, thus suggesting
that p38α and p38β may have different functions in bone formation.
To elucidate the in vivo role of p38α in regulating osteoblast func-
tion, we generated mice lacking p38α in mature osteoblasts. Mice
expressing Cre recombinase under the control of the osteocalcin
promoter (Ocn-Cre) were crossed with mice harboring floxed p38α-
encoding gene (p38αf/f). The bone phenotype of control (p38αf/f) and
mutant (Ocn-Cre;p38αf/f) mice was assessed by dual energy X-ray
absorptiometry, micro-computed tomography and gene expression
analyses at 3 months of age (n = 6 per group). Mutant mice exhibited
lower bone mineral density compared to control mice (–8.2 %, p =
0.003). Ocn-Cre;p38αf/f mice displayed an important reduction in
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trabecular bone volume at the distal femoral metaphysis (–37.1 %,
p = 0.002) associated with low trabecular thickness (–20.7 %,
p < 0.001). A similar pattern of low trabecular bone mass was observed
at the fifth lumbar vertebral body. In addition, Ocn-Cre;p38αf/f mice
also showed decreased cortical thickness at the femoral midshaft
(–20.2 %, p < 0.001). Consistent with this low bone mass pheno-
type, Osx, Col1a1, Alp and Ocn expressions were reduced by 34, 32,
10 and 40 % in long bones of mutant mice, respectively. Finally,
primary p38α knockout osteoblasts demonstrated lower Osx, Col1a1,
Alp and Ocn expressions (p ≤ 0.01) and reduced capacity to miner-
alize in-vitro, indicating a defective function of osteoblasts lacking
p38α. These findings indicate that p38α is an essential regulator of
osteoblast function and bone formation in vivo.
External mechanical microstimuli improves
osseointegration of titanium implants in rat
proximal tibiae
G. Zacchetti 1, A. Wiskott 2, J. Cugnoni 3, I. Botsis 3, P. Ammann1
1Division of Bone Disease, Department of Rehabilitation and Geriatrics
and Faculty of Medicine, University Hospital of Geneva, Geneva,
2Laboratory of biomaterials, School of Dentistry, University of Geneva,
3Laboratory of Applied Mechanics and Reliability Analysis, École Poly-
technique Fédérale de Lausanne, Switzerland
A poor osseointegration of endosseous implants is the cause of early
implants failure compromising the outcome of a surgical interven-
tion both in dentistry and orthopedics. The aim of this work was to
measure the effect on implant osseointegration in rat proximal tib-
iae following the application of external mechanical microstimuli
of controlled intensity. Increasing loads were selected and a dose-
dependent effect on parameters of implant osseointegration was
researched. 40 females rats 6 months old were operated at the right
tibiae by transcutaneous insertion of two titan cylindrical implants,
respectively 1 mm and 0.8 mm of diameter. The stimulated implant
was fixed within the trabecular bone of the secondary spongiosa
whereas the anchorage implant was inserted 8 mm distal, encom-
passing both cortical surfaces. After 2 weeks rats were assigned to
4 groups (non stimulated, 1N, 2N 3N), and further underwent to a
daily external mechanical stimulation during 4 weeks. Ultimate
Strength (US) was measured ex-vivo by a pull-out test as indicator
of implant osseointegration. Both determinants of pullout strength
BV/TV and the number of bone/implant contacts (BIC) were eval-
uated by microcomputerized tomography (micro-Ct) within the
trabecular bone adjacent the proximal implant (Table 2). Values are
± SEM, and significant differences were identified by t-test (< 0.05).
Higher US values were observed in stimulated animals, the group
2N displaying a significant increase of the pull-out force necessary
to loosen the implant compared to non-stimulated control rats. The
modest increase in BV/TV and bone/implant contacts observed in
stimulated implants is not sufficient to explain the increase in US
observed in 2N group. We hypothesize that ingrowths within the
etched implant surface may explain it. In conclusion, application of
external mechanical microstimuli of controlled intensity improves
osseointegration of titanium implants in rat proximal tibiae.
SBMS-Tagung – Abstracts
Table 2. Results, Zacchetti G et al.
Stimulation Non 1 N 2 N 3 N
stimulated (ca 1250 µε) (ca 2500 µε) (ca 3750 µε)
US (N) 39.57 ± 2.23 40.82 ± 3.12 46.63 ± 2.21* 43.81 ± 3.41
BV/TV (%) 44.2 ± 3.1 50.5 ± 2.3 48.5 ± 1.9 48.0 ± 3.9
BIC (%) 76.02 ± 2.66 78.73 ± 2.25 78.35 ± 2.19 76.85 ± 3.70
*p < 0.05 compared to non stimulated controls (t-test)
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